Uloric and Zaditor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Uloric (febuxostat) and Zaditor (ketotifen fumarate). Common drug interactions include death among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Uloric and Zaditor. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Uloric?

Uloric has active ingredients of febuxostat. It is often used in gout. eHealthMe is studying from 8,067 Uloric users. Check the latest studies of Uloric.

What is Zaditor?

Zaditor has active ingredients of ketotifen fumarate. It is often used in eye allergy. eHealthMe is studying from 4,448 Zaditor users. Check the latest studies of Zaditor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

16 people who take Uloric and Zaditor together, and have interactions are studied.

What are the common drug interactions of Uloric and Zaditor, by gender? *:

female:

Death

male:

Depression
Hospitalisation
Weight increased
Diarrhoea
Insomnia (sleeplessness)
Cough
Hypersensitivity
Oral discomfort (pain or irritation in mouth)
Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
Suicidal ideation

What are the common drug interactions of Uloric and Zaditor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Diarrhoea
Insomnia (sleeplessness)

30-39:

Ankle fracture
Confusional state
Encephalopathy (functioning of the brain is affected by some agent or condition)
Lung disorder (lung disease)
Somnolence (a state of near-sleep, a strong desire for sleep)
Therapeutic response unexpected

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 87.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 68.75%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 6.25%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 6.25%
Joint Pain: 1 person, 6.25%
Bone Pain: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Uloric and Zaditor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously